Answer
Alunbrig (brigatinib) is used alone to treat adults with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer who have not previously received an ALK inhibitor or who have previously received crizotinib.
Sources for this answer
- Alunbrig 30 mg film-coated tabletsTakeda UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 10Document updated
Sources checked